Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease

Erik V. Soloff, Atif Zaheer, Jeffrey Meier, Marc Zins, Eric P. Tamm

Research output: Contribution to journalArticlepeer-review

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a relatively common malignancy that carries an overall poor prognosis, with five-year survival below 10%. Despite ongoing research, surgical resection remains the only potentially curative treatment. Therefore, accurate identification of those patients who would benefit from surgical resection is of paramount importance. High-quality imaging and image interpretation is central to this process. Radiology helps in the determination of whether patients are resectable, borderline resectable, or unresectable and guides treatment planning.

Original languageEnglish (US)
Pages (from-to)301-313
Number of pages13
JournalAbdominal Radiology
Volume43
Issue number2
DOIs
StatePublished - Feb 1 2018

Keywords

  • Pancreatic ductal adenocarcinoma (PDAC)
  • Preoperative staging
  • Resectability
  • Vasculature

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging
  • Gastroenterology
  • Urology

Fingerprint

Dive into the research topics of 'Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease'. Together they form a unique fingerprint.

Cite this